BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 12093891)

  • 21. Encephalitogenic and tolerogenic potential of altered peptide ligands of MOG and PLP in Biozzi ABH mice.
    Heijmans N; Smith PA; Morris-Downes MM; Pryce G; Baker D; Donaldson AV; 't Hart B; Amor S
    J Neuroimmunol; 2005 Oct; 167(1-2):23-33. PubMed ID: 16054237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system.
    Linington C; Berger T; Perry L; Weerth S; Hinze-Selch D; Zhang Y; Lu HC; Lassmann H; Wekerle H
    Eur J Immunol; 1993 Jun; 23(6):1364-72. PubMed ID: 7684687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
    Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H
    Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OSP/claudin-11-induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179-207.
    Kaushansky N; Hemo R; Eisenstein M; Ben-Nun A
    Eur J Immunol; 2007 Jul; 37(7):2018-31. PubMed ID: 17549734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of MS-like disease by a multi epitope protein is mediated by induction of CD11c
    Kaushansky N; Kaminitz A; Allouche-Arnon H; Ben-Nun A
    J Neuroimmunol; 2019 Aug; 333():476953. PubMed ID: 31108399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myelin-reactive antibodies mediate the pathology of MBP-PLP fusion protein MP4-induced EAE.
    Kuerten S; Pauly R; Rottlaender A; Rodi M; Gruppe TL; Addicks K; Tary-Lehmann M; Lehmann PV
    Clin Immunol; 2011 Jul; 140(1):54-62. PubMed ID: 21489887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes.
    Samson MF; Smilek DE
    J Immunol; 1995 Sep; 155(5):2737-46. PubMed ID: 7544383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE.
    Xu B; Haviernik P; Wolfraim LA; Bunting KD; Scott DW
    Mol Ther; 2006 Jan; 13(1):42-8. PubMed ID: 16219491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes.
    Finn TP; Jones RE; Rich C; Dahan R; Link J; David CS; Chou YK; Offner H; Vandenbark AA
    J Neurosci Res; 2004 Oct; 78(1):100-14. PubMed ID: 15372502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
    Yu M; Johnson JM; Tuohy VK
    J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis.
    Kel J; Oldenampsen J; Luca M; Drijfhout JW; Koning F; Nagelkerken L
    Am J Pathol; 2007 Jan; 170(1):272-80. PubMed ID: 17200200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A structurally available encephalitogenic epitope of myelin oligodendrocyte glycoprotein specifically induces a diversified pathogenic autoimmune response.
    Bischof F; Bins A; Dürr M; Zevering Y; Melms A; Kruisbeek AM
    J Immunol; 2004 Jul; 173(1):600-6. PubMed ID: 15210822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epitope spread is not critical for the relapse and progression of MOG 8-21 induced EAE in Biozzi ABH mice.
    Smith PA; Morris-Downes M; Heijmans N; Pryce G; Arter E; O'Neill JK; 't Hart B; Baker D; Amor S
    J Neuroimmunol; 2005 Jul; 164(1-2):76-84. PubMed ID: 15927270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential prevention of experimental autoimmune encephalomyelitis with antigen-specific DNA vaccination.
    Walczak A; Szymanska B; Selmaj K
    Clin Neurol Neurosurg; 2004 Jun; 106(3):241-5. PubMed ID: 15177776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
    Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel RP
    J Exp Med; 1999 Apr; 189(7):1033-42. PubMed ID: 10190894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral Administration of Lactococcus lactis Expressing Synthetic Genes of Myelin Antigens in Decreasing Experimental Autoimmune Encephalomyelitis in Rats.
    Kasarello K; Kwiatkowska-Patzer B; Lipkowski AW; Bardowski JK; Szczepankowska AK
    Med Sci Monit; 2015 May; 21():1587-97. PubMed ID: 26026273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In trans T cell tolerance diminishes autoantibody responses and exacerbates experimental allergic encephalomyelitis.
    Bell JJ; Divekar RD; Ellis JS; Cascio JA; Haymaker CL; Jain R; Tartar DM; Hoeman CM; Hardaway JC; Zaghouani H
    J Immunol; 2008 Feb; 180(3):1508-16. PubMed ID: 18209046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential patterns of spinal cord pathology induced by MP4, MOG peptide 35-55, and PLP peptide 178-191 in C57BL/6 mice.
    Kuerten S; Gruppe TL; Laurentius LM; Kirch C; Tary-Lehmann M; Lehmann PV; Addicks K
    APMIS; 2011 Jun; 119(6):336-46. PubMed ID: 21569091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis.
    Fridkis-Hareli M; Santambrogio L; Stern JN; Fugger L; Brosnan C; Strominger JL
    J Clin Invest; 2002 Jun; 109(12):1635-43. PubMed ID: 12070311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.